Plant Essential Oils as Healthy Functional Ingredients of Nutraceuticals and Diet Supplements: A Review.
Riccardo MateraElena LucchiLuca ValgimigliPublished in: Molecules (Basel, Switzerland) (2023)
Essential oils (EOs) are mixtures of volatile molecules endowed with health-promoting biological activities that go beyond their role as aromas and natural preservatives and can be exploited to develop functional foods and diet supplements. Their composition is briefly addressed along with regulatory aspects. The potential health benefit of human diet supplementation with EOs is outlined through a review of the recent literature on available clinical trials and preclinical research concerning EOs activity towards: (1) irritable bowel syndrome; (2) inflammatory bowel disease; (3) regulation of microbiota; (4) gastroprotection; (5) hepatoprotection; (6) protection of the urinary tract and diuresis; (7) management of metabolic disorders including hyperglycemia and hyperlipidemia; (8) anti-inflammatory and pain control; (9) immunomodulation and protection from influenza; and (10) neuroprotection and modulation of mood and cognitive performance. The emerging potential in such activities of selected EOs is given focus, particularly green and black cumin, bergamot, orange, myrtle, peppermint, sage, eucalyptus, lavender, thyme, lemon balm, ginger, and garlic.
Keyphrases
- irritable bowel syndrome
- weight loss
- physical activity
- urinary tract
- public health
- essential oil
- healthcare
- clinical trial
- human health
- anti inflammatory
- mental health
- chronic pain
- endothelial cells
- systematic review
- health information
- bipolar disorder
- transcription factor
- brain injury
- health promotion
- risk assessment
- high fat diet
- cell therapy
- type diabetes
- stem cells
- induced pluripotent stem cells
- ionic liquid
- randomized controlled trial
- blood brain barrier
- pluripotent stem cells
- sleep quality
- depressive symptoms
- mesenchymal stem cells
- metabolic syndrome
- mass spectrometry
- insulin resistance
- cerebral ischemia
- diabetic rats
- phase ii
- study protocol
- simultaneous determination
- gas chromatography
- solid phase extraction